VIVS

VivoSim Labs Inc

0.2394

-0.0089-3.58%

Opening14:37 09/22 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.2590/0.2483

TODAY RANGE0.2320-0.2590

VOL1.00M

MARKET CAP3.97M

52 WEEK RANGE0.2167-4.114

AVG VOL (3M)5.85M

% TURNOVER5.99%

TURNOVER--

P/E (TTM)-0.0538

% RANGE10.87%

EPS(TTM)-4.4506

P/E(FORWARD)-0.0266

P/B-0.3260

BVPS-0.7344

DIVIDEND--

P/S5.28

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP3.86M

SHARES OUTSTANDING16.59M

NEXT EARNINGS11/04-11/09

FREE FLOAT16.14M

LOT SIZE1

EX-DATE03/21/2025

News

Press Releases

Financial Reports

Profile

NASDAQ·6d ago
VivoSim Labs Presents New NAMkind Data At EUROTOX 2026
TipRanks·08/21 20:36
VivoSim Labs Faces Nasdaq Minimum Bid Price Deficiency
TipRanks·08/06 13:56
VivoSim regains compliance with Nasdaq
TipRanks·07/30 21:06
VivoSim Labs Sets 2026 Annual Shareholder Meeting Date
TipRanks·07/24 20:32
VivoSim Labs Addresses Nasdaq Listing Compliance Concerns
TipRanks·07/21 12:45
VivoSim enters China with first commercial sales of NAMkind testing services
TipRanks·07/17 13:17
VivoSim Labs Announces $4 Million Private Placement Financing
Seeking Alpha·07/16 13:07
VivoSim prices $4.0M private placement
TipRanks·07/15 13:16
Why Is Penny Stock VivoSim Labs (VIVS) Up Today?
TipRanks·07/15 12:51
VivoSim receives $5M milestone payment from Eli Lilly
TipRanks·07/15 12:51
VivoSim sees FY27 revenue up over 500%
Seeking Alpha·07/15 12:12
VivoSim expects FY27 revenue growth of over 500%, receives $5M milestone payment from Eli Lilly
Dow Jones·07/15 12:11
*VivoSim Labs Sees FY27 Rev Growing Significantly >VIVS
Dow Jones·07/15 12:05
Press Release: VivoSim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That It Expects Revenue Growth of 500%+ in FY2027
TipRanks·06/29 22:17
VivoSim Labs Delays Annual SEC Filing

Same Industry

Name/Symbol

Change%

Price

VIVS

REGN

GridAI Tech

GRDX

+5.59%

3.590

BIONTECH

BNTX

+2.02%

98.00

United Therapeutics Corp.

UTHR

-0.31%

493.10

Vertex Pharmaceuticals Inc

VRTX

-1.55%

508.34

Siga Technologie

SIGA

+2.95%

3.140

Moderna

MRNA

+9.74%

169.04

Charles Riv Labs Intl Inc

CRL

-1.28%

278.06

MEDP

TLPH

ICON plc

ICLR

+3.31%

169.55

CBPO

IQV

MOLN

Arcturus Therape

ARCT

-5.32%

16.03

Gilead Sciences Inc

GILD

-0.52%

150.11

PRAH

Aptevo Therapeutics Inc

APVO

0.00%

1.840

Incyte Corp

INCY

-0.53%

124.65

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.